gh one of the world's largest
retailers, Costco," stated Thierry Houillon, Vice-President, Nutraceutical
of Neptune. "Schiff Nutrition's track record and experience in the $22
billion(x) U.S. dietary supplement market will ensure that a broader
portion of the population will now benefit from our product. Costco
operates in 385 U.S. locations and reported total annual revenues beyond
$60 billion and 50.4 million cardholders. Entering alliances that leverage
each partner's marketing and commercialization network, strength and
expertise is part of Neptune's business strategy," he added.
About Neptune Technologies & Bioressources Inc.
Neptune develops proprietary health ingredients from underexploited
marine biomasses, such as krill, with its patented extraction process
(Neptune OceanExtract(TM)). Using its proprietary process, the Company is
strategically positioning itself in the health and wellness market.
Natural biomass extraction is now playing an important role in
developing nutrigenomics, the next wave in nutritional research. Through
strategic alliances and partnerships, as well as through clinical studies,
the Company continues to demonstrate the beneficial effects of these
products. The Company develops and markets new formulas and new products
for specific applications in high growth markets such as the nutraceutical,
cosmeceutical, biopharmaceutical and nutrigenomics markets.
Neptune continues to strongly support its strategic development plan to
form partnerships/strategic alliances with worldwide leaders in the
nutraceutical and pharmaceutical industries. Neptune has recently signed
agreements with Nestle and Yoplait, worldwide leading food manufacturers,
paving its entrance into the global functional food market. According to
its business strategy, negotiations with pharmaceutical companies with the
objective of entering the pharmaceutical market by licensing rights are
ongoing.
NASDAQ and TSX venture exchange do
'/>"/>
SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results2.
Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update3.
Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board4.
Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering5.
Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction6.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results7.
BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery8.
Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators9.
China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day10.
Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth11.
Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership